보건 안보 리스크 지수
INFORM-style aggregation, on 0 to 10, of epidemic and AMR hazard, disease burden and undernutrition against health-system and IHR capacity, each component oriented by its own polarity.
geometric
expert weights · floor 0.1 where geometric
1,000 draws
normalisation, weights, aggregation, imputation
5 components
25 leaf indicators
67% minimum
modelled share ≤ 20%
From indicators to the composite
Shows where an outbreak is likely, where it would land on a vulnerable population and where the system could not contain it; each sub-index stays visible.
- 감염병 유행 사건 빈도Indicator · IND · 1Average annual number of distinct infectious-disease outbreak events in the country reported by WHO or a regional public-health agency over the latest five years, counting each event once whatever its duration.
- 보고된 콜레라 환자 수, 인구 100,000명당Indicator · IND · /10*5Cholera cases reported to WHO in the year per 100,000 of the mid-year population.
- MRSA로 인한 혈류 감염Indicator · IND · %Share of Staphylococcus aureus bloodstream infections that are methicillin-resistant, among patients with a tested blood sample.
- 3세대 세팔로스포린 내성 대장균(E. coli)으로 인한 혈류 감염Indicator · IND · %Share of Escherichia coli bloodstream infections resistant to third-generation cephalosporins, among patients with a tested blood sample.
- 5세 미만 사망률Indicator · IND · /10*3Probability, per 1,000 live births, that a child born in the year dies before reaching age five at current age-specific mortality.
- 모성 사망비Indicator · IND · /10*5Deaths of women from pregnancy-related causes during pregnancy or within 42 days of its end, per 100,000 live births, as modelled by the UN inter-agency group.
- 주요 비감염성 질환으로 인한 조기 사망률Indicator · IND · %Probability, in percent, of dying between exact ages 30 and 70 from cardiovascular disease, cancer, diabetes or chronic respiratory disease.
- 결핵 발생률Indicator · IND · /10*5Estimated new and relapse tuberculosis cases of all forms per 100,000 population in the year.
- 말라리아 발생률Indicator · IND · /10*3Estimated new malaria cases per 1,000 people living in areas at risk of transmission.
- HIV 발생률Indicator · IND · /10*3New HIV infections in the year per 1,000 uninfected people of all ages.
- 5세 미만 아동의 발육부진Indicator · IND · %Share of children under five whose height-for-age is more than two standard deviations below the WHO Child Growth Standards median (modelled estimate).
- 5세 미만 아동의 소모증Indicator · IND · %Share of children under five whose weight-for-height is more than two standard deviations below the WHO Child Growth Standards median, from the latest national survey.
- 가임기 여성의 빈혈Indicator · IND · %Share of women aged 15 to 49 with haemoglobin below the WHO threshold for their pregnancy status, adjusted for altitude and smoking.
- 인구 1,000명당 의사 수Indicator · IND · /10*3Practising or professionally active medical doctors, generalists and specialists, per 1,000 population.
- 인구 1,000명당 간호사 및 조산사 수Indicator · IND · /10*3Nursing and midwifery personnel, professional and associate, per 1,000 population.
- 인구 1,000명당 병상 수Indicator · IND · /10*3Inpatient beds in public, private, general and specialised hospitals and rehabilitation centres, per 1,000 population.
- UHC 서비스 보장 지수Indicator · IND · scoreIndex from 0 to 100 of the average coverage of essential services across reproductive, maternal, newborn and child health, infectious disease, non-communicable disease and service capacity and access.
- DTP3 예방접종률Indicator · IND · %Share of surviving infants who received the third dose of diphtheria-tetanus-pertussis-containing vaccine, as estimated by WHO and UNICEF.
- 홍역 2차 예방접종률Indicator · IND · %Share of children who received the second dose of measles-containing vaccine by the nationally recommended age.
- 숙련 보건 인력이 입회한 출산Indicator · IND · %Share of live births attended by a doctor, nurse or midwife trained to manage normal deliveries and refer complications.
- 경상 의료비, GDP 대비 비율Indicator · IND · %Spending on health goods and services consumed in the year, from all financing sources, as a percentage of GDP (SHA 2011).
- IHR 실험실 역량(SPAR C4)Indicator · IND · scoreSelf-reported SPAR score, from 0 to 100, for national laboratory systems: specimen referral and transport, biosafety, quality and testing for priority pathogens.
- IHR 감시 역량(SPAR C5)Indicator · IND · scoreSelf-reported SPAR score, from 0 to 100, for early-warning, event-based and indicator-based surveillance and event verification.
- IHR 보건 비상 관리 역량(SPAR C7)Indicator · IND · scoreSelf-reported SPAR score, from 0 to 100, for emergency risk assessment, preparedness planning, emergency operations and logistics.
- IHR 위험 소통 역량(SPAR C10)Indicator · IND · scoreSelf-reported SPAR score, from 0 to 100, for risk communication systems, community engagement and management of misinformation in emergencies.
- Epidemic and AMR hazard sub-indexSub-index · SUB · w 1 · 22.2%Composite of outbreak event frequency, reported cholera and resistance among MRSA and E. coli bloodstream infections.
- Disease burden sub-indexSub-index · SUB · w 1 · 22.2%Composite of under-five and maternal mortality, premature non-communicable disease mortality and the incidence of tuberculosis, malaria and HIV.
- Undernutrition sub-indexSub-index · SUB · w 0.5 · 11.1%Composite of child stunting, child wasting and anaemia among women of reproductive age.
- Health-system capacity sub-indexSub-index · SUB · w 1 · 22.2%Composite of doctor, nurse and bed density, UHC service coverage, routine immunisation, skilled birth attendance and health spending.
- IHR operational capacity sub-indexSub-index · SUB · w 1 · 22.2%Composite of the SPAR laboratory, surveillance, health emergency management and risk communication capacity scores.
- 보건 안보 리스크 지수Domain index · IDX · geometricINFORM-style aggregation, on 0 to 10, of epidemic and AMR hazard, disease burden and undernutrition against health-system and IHR capacity, each component oriented by its own polarity.
- 인간 및 시스템 취약성Pillar · PILLAR · 8 indicesHow susceptible are people, livelihoods, ecosystems and essential systems to harm when a shock arrives?
- NXS-GRX (canonical data, provenance and risk) Composite RiskComposite · COMPOSITE · four pillarsComposite = (HTE × VUL × MSF × LCC)^(1/4), each pillar on 0–10 floored at 0.1; pillar = expert-weighted geometric mean of its domain indices
Run this index’s own aggregation
Set each component, change the aggregation or the weight uncertainty, and watch the interval, the class probability and each component’s contribution respond.
Treatment, normalisation, weighting, aggregation, uncertainty
- Treatment
- WINSORISE
- Outlier rule
- |skew| > 2, kurtosis > 3.5
- Normalisation
- INFORM 0–10 rescaling
- Imputation
- NONE
- Coverage minimum
- 67% of components
- Modelled share cap
- 20% of weight
- Weighting
- 전문가
- Aggregation
- geometric
- Scale
- 0 to 10
- 불확실성
- 1,000 Monte Carlo runs over normalisation, weights, aggregation, imputation
- Framework basis
- INFORM Risk methodology (geometric dimensions); IHR (2005) monitoring framework; JRC COIN 10-step guide; OECD/JRC Handbook (2008)
5 components, 25 indicators
Epidemic and AMR hazard sub-index w 1
Composite of outbreak event frequency, reported cholera and resistance among MRSA and E. coli bloodstream infections.
| 지표 | 단위 | 근거 | 출처 | 비중 |
|---|---|---|---|---|
감염병 유행 사건 빈도IND.HLT.epidemic.outbreak_event_frequency | 1 | Class B | who-disease-outbreak-news, who-weekly-bulletin-afro, africa-cdc-epidemic-intelligence | 40.0% |
보고된 콜레라 환자 수, 인구 100,000명당IND.HLT.epidemic.cholera_cases.p100k | /10*5 | Class B | who-gho, who-cholera-annual-report | 20.0% |
MRSA로 인한 혈류 감염IND.HLT.amr.mrsa_bloodstream | % | Class B | who-glass, who-gho | 20.0% |
3세대 세팔로스포린 내성 대장균(E. coli)으로 인한 혈류 감염IND.HLT.amr.ecoli_3gc_bloodstream | % | Class B | who-glass, who-gho | 20.0% |
Disease burden sub-index w 1
Composite of under-five and maternal mortality, premature non-communicable disease mortality and the incidence of tuberculosis, malaria and HIV.
| 지표 | 단위 | 근거 | 출처 | 비중 |
|---|---|---|---|---|
5세 미만 사망률IND.HLT.burden.under5_mortality | /10*3 | Class C | un-igme, wb-wdi, who-gho | 16.7% |
모성 사망비IND.HLT.burden.maternal_mortality | /10*5 | Class C | un-mmeig, wb-wdi, who-gho | 16.7% |
주요 비감염성 질환으로 인한 조기 사망률IND.HLT.burden.ncd_premature_mortality | % | Class C | who-ghe, wb-wdi | 16.7% |
결핵 발생률IND.HLT.burden.tb_incidence | /10*5 | Class C | who-global-tb-programme, wb-wdi | 16.7% |
말라리아 발생률IND.HLT.burden.malaria_incidence | /10*3 | Class C | who-world-malaria-report, wb-wdi | 16.7% |
HIV 발생률IND.HLT.burden.hiv_incidence | /10*3 | Class C | unaids, wb-wdi, who-gho | 16.7% |
Undernutrition sub-index w 0.5
Composite of child stunting, child wasting and anaemia among women of reproductive age.
| 지표 | 단위 | 근거 | 출처 | 비중 |
|---|---|---|---|---|
5세 미만 아동의 발육부진IND.HLT.nutrition.stunting | % | Class C | unicef-who-wb-jme, wb-wdi, who-gho | 33.3% |
5세 미만 아동의 소모증IND.HLT.nutrition.wasting | % | Class B | unicef-who-wb-jme, wb-wdi, smart-surveys | 33.3% |
가임기 여성의 빈혈IND.HLT.nutrition.anaemia_women | % | Class C | who-gho, wb-wdi | 33.3% |
Health-system capacity sub-index w 1
Composite of doctor, nurse and bed density, UHC service coverage, routine immunisation, skilled birth attendance and health spending.
| 지표 | 단위 | 근거 | 출처 | 비중 |
|---|---|---|---|---|
인구 1,000명당 의사 수IND.HLT.system.physician_density | /10*3 | Class B | who-nhwa, wb-wdi | 11.1% |
인구 1,000명당 간호사 및 조산사 수IND.HLT.system.nurse_midwife_density | /10*3 | Class B | who-nhwa, wb-wdi | 11.1% |
인구 1,000명당 병상 수IND.HLT.system.hospital_beds | /10*3 | Class B | who-gho, wb-wdi, oecd-health | 11.1% |
UHC 서비스 보장 지수IND.HLT.system.uhc_service_coverage | {score} | Class C | who-gho, wb-wdi | 22.2% |
DTP3 예방접종률IND.HLT.system.dtp3_coverage | % | Class C | who-unicef-wuenic, wb-wdi | 11.1% |
홍역 2차 예방접종률IND.HLT.system.mcv2_coverage | % | Class C | who-unicef-wuenic, wb-hnp-stats | 11.1% |
숙련 보건 인력이 입회한 출산IND.HLT.system.skilled_birth_attendance | % | Class B | unicef-who-joint-database, wb-wdi | 11.1% |
경상 의료비, GDP 대비 비율IND.HLT.system.health_expenditure.gdp | % | Class B | who-ghed, wb-wdi | 11.1% |
IHR operational capacity sub-index w 1
Composite of the SPAR laboratory, surveillance, health emergency management and risk communication capacity scores.
| 지표 | 단위 | 근거 | 출처 | 비중 |
|---|---|---|---|---|
IHR 실험실 역량(SPAR C4)IND.HLT.security.spar_laboratory | {score} | Class B | who-spar, who-jee | 25.0% |
IHR 감시 역량(SPAR C5)IND.HLT.security.spar_surveillance | {score} | Class B | who-spar, who-jee | 25.0% |
IHR 보건 비상 관리 역량(SPAR C7)IND.HLT.security.spar_emergency_management | {score} | Class B | who-spar, who-jee | 25.0% |
IHR 위험 소통 역량(SPAR C10)IND.HLT.security.spar_risk_communication | {score} | Class B | who-spar, who-jee | 25.0% |
보건
Disease burden, health-system capacity and health-security preparedness.
| Sub-domain | 지표 |
|---|---|
| Disease burden and mortality | 8 |
| Health system capacity | 11 |
| Health security (IHR) | 5 |
| Epidemic and outbreak | 2 |
| Antimicrobial resistance | 2 |
| Nutrition | 3 |
Anchor frameworks (pillar structure and definitions only): WHO GHO; IHR JEE 3rd ed.; IHR SPAR 2nd ed.; SDG 3.
All 31 health indicators
| 지표 | 영역 | Sub-domain | 구성 요소 | 단위 | 단계 | Crosswalks |
|---|---|---|---|---|---|---|
5세 미만 사망률IND.HLT.burden.under5_mortality | HLT | Disease burden and mortality | vulnerability | /10*3 | COUNTRY | WB_WDI SH.DYN.MORT SDG 3.2.1 WHO_GHO MDG_0000000007 |
신생아 사망률IND.HLT.burden.neonatal_mortality | HLT | Disease burden and mortality | vulnerability | /10*3 | COUNTRY | WB_WDI SH.DYN.NMRT SDG 3.2.2 |
모성 사망비IND.HLT.burden.maternal_mortality | HLT | Disease burden and mortality | vulnerability | /10*5 | COUNTRY | WB_WDI SH.STA.MMRT SDG 3.1.1 WHO_GHO MDG_0000000026 |
출생 시 기대수명IND.HLT.burden.life_expectancy | HLT | Disease burden and mortality | vulnerability | a | COUNTRY | WB_WDI SP.DYN.LE00.IN WHO_GHO WHOSIS_000001 |
주요 비감염성 질환으로 인한 조기 사망률IND.HLT.burden.ncd_premature_mortality | HLT | Disease burden and mortality | vulnerability | % | COUNTRY | WB_WDI SH.DYN.NCOM.ZS SDG 3.4.1 WHO_GHO NCDMORT3070 |
결핵 발생률IND.HLT.burden.tb_incidence | HLT | Disease burden and mortality | hazard | /10*5 | COUNTRY | WB_WDI SH.TBS.INCD SDG 3.3.2 WHO_GHO MDG_0000000020 |
말라리아 발생률IND.HLT.burden.malaria_incidence | HLT | Disease burden and mortality | hazard | /10*3 | COUNTRY | WB_WDI SH.MLR.INCD.P3 SDG 3.3.3 WHO_GHO SDGMALARIA |
HIV 발생률IND.HLT.burden.hiv_incidence | HLT | Disease burden and mortality | hazard | /10*3 | COUNTRY | WB_WDI SH.HIV.INCD.TL.P3 SDG 3.3.1 WHO_GHO SDGHIV WB_WDI SH.HIV.INCD.ZS |
인구 1,000명당 의사 수IND.HLT.system.physician_density | HLT | Health system capacity | coping capacity | /10*3 | COUNTRY | WB_WDI SH.MED.PHYS.ZS WHO_GHO HWF_0001 SDG 3.c.1 |
인구 1,000명당 간호사 및 조산사 수IND.HLT.system.nurse_midwife_density | HLT | Health system capacity | coping capacity | /10*3 | COUNTRY | WB_WDI SH.MED.NUMW.P3 WHO_GHO HWF_0006 SDG 3.c.1 |
인구 1,000명당 병상 수IND.HLT.system.hospital_beds | HLT | Health system capacity | coping capacity | /10*3 | COUNTRY | WB_WDI SH.MED.BEDS.ZS WHO_GHO WHS6_102 |
UHC 서비스 보장 지수IND.HLT.system.uhc_service_coverage | HLT | Health system capacity | coping capacity | {score} | COUNTRY | SDG 3.8.1 WHO_GHO UHC_INDEX_REPORTED WB_WDI SH.UHC.SRVS.CV.XD |
과부담 본인부담 의료비 지출 인구IND.HLT.system.catastrophic_oop | HLT | Health system capacity | vulnerability | % | COUNTRY | SDG 3.8.2 WB_WDI SH.UHC.OOPC.10.ZS |
본인부담 지출, 경상 의료비 대비 비율IND.HLT.system.oop_share | HLT | Health system capacity | vulnerability | % | COUNTRY | WB_WDI SH.XPD.OOPC.CH.ZS WHO_GHO GHED_OOPSCHE_SHA2011 |
경상 의료비, GDP 대비 비율IND.HLT.system.health_expenditure.gdp | HLT | Health system capacity | coping capacity | % | COUNTRY | WB_WDI SH.XPD.CHEX.GD.ZS |
DTP3 예방접종률IND.HLT.system.dtp3_coverage | HLT | Health system capacity | coping capacity | % | COUNTRY | WHO_GHO WHS4_100 WB_WDI SH.IMM.IDPT SDG 3.b.1 |
홍역 2차 예방접종률IND.HLT.system.mcv2_coverage | HLT | Health system capacity | coping capacity | % | COUNTRY | WHO_GHO MCV2 WB_WDI SH.IMM.MEA2 SDG 3.b.1 |
숙련 보건 인력이 입회한 출산IND.HLT.system.skilled_birth_attendance | HLT | Health system capacity | coping capacity | % | COUNTRY | WB_WDI SH.STA.BRTC.ZS SDG 3.1.2 |
가장 가까운 보건 시설까지 이동 시간IND.HLT.system.health_facility_travel_time | HLT | Health system capacity | vulnerability | min | COUNTRY, ADM1, ADM2, CITY, GRID | |
IHR 핵심 역량 점수(SPAR)IND.HLT.security.spar_capacity | HLT | Health security (IHR) | coping capacity | {score} | COUNTRY | SDG 3.d.1 WHO_GHO SDGIHR2021 WHO_GHO SDGIHR2018 |
IHR 실험실 역량(SPAR C4)IND.HLT.security.spar_laboratory | HLT | Health security (IHR) | coping capacity | {score} | COUNTRY | SPAR C4 WHO_GHO IHRSPAR2_C04 JEE D1 |
IHR 감시 역량(SPAR C5)IND.HLT.security.spar_surveillance | HLT | Health security (IHR) | coping capacity | {score} | COUNTRY | SPAR C5 WHO_GHO IHRSPAR2_C05 JEE D2 |
IHR 보건 비상 관리 역량(SPAR C7)IND.HLT.security.spar_emergency_management | HLT | Health security (IHR) | coping capacity | {score} | COUNTRY | SPAR C7 WHO_GHO IHRSPAR2_C07 JEE R1 |
IHR 위험 소통 역량(SPAR C10)IND.HLT.security.spar_risk_communication | HLT | Health security (IHR) | coping capacity | {score} | COUNTRY | SPAR C10 WHO_GHO IHRSPAR2_C10 JEE R5 |
감염병 유행 사건 빈도IND.HLT.epidemic.outbreak_event_frequency | HLT | Epidemic and outbreak | hazard | 1 | COUNTRY, ADM1 | |
보고된 콜레라 환자 수, 인구 100,000명당IND.HLT.epidemic.cholera_cases.p100k | HLT | Epidemic and outbreak | hazard | /10*5 | COUNTRY | WHO_GHO CHOLERA_0000000001 |
MRSA로 인한 혈류 감염IND.HLT.amr.mrsa_bloodstream | HLT | Antimicrobial resistance | hazard | % | COUNTRY | WHO_GHO AMR_INFECT_MRSA SDG 3.d.2 |
3세대 세팔로스포린 내성 대장균(E. coli)으로 인한 혈류 감염IND.HLT.amr.ecoli_3gc_bloodstream | HLT | Antimicrobial resistance | hazard | % | COUNTRY | WHO_GHO AMR_INFECT_ECOLI SDG 3.d.2 |
5세 미만 아동의 발육부진IND.HLT.nutrition.stunting | HLT | Nutrition | vulnerability | % | COUNTRY | WB_WDI SH.STA.STNT.ME.ZS SDG 2.2.1 WHO_GHO NUTSTUNTINGPREV FAO_FAOSTAT 21025 |
5세 미만 아동의 소모증IND.HLT.nutrition.wasting | HLT | Nutrition | vulnerability | % | COUNTRY, ADM1 | WB_WDI SH.STA.WAST.ZS SDG 2.2.2 WHO_GHO NUTRITION_WH_2 FAO_FAOSTAT 21026 |
가임기 여성의 빈혈IND.HLT.nutrition.anaemia_women | HLT | Nutrition | vulnerability | % | COUNTRY | WB_WDI SH.ANM.ALLW.ZS WHO_GHO NUTRITION_ANAEMIA_REPRODUCTIVEAGE_PREV SDG 2.2.3 FAO_FAOSTAT 21043 |
Health security risk index, world
The world reading of this index, every country as a tile and the largest movements since the previous edition.
- 이전 판
- –
- Range since 2016
- –
- 결합 종합
- –
- 결합 점수 S
- –
- 동향, 최근 1주
- –
- Outlook, 12 months
- –
- 방법
- Indicator Standard 1.0 · NXS-GRX 2026
- 추출
- 1,000
아직 공개된 값이 없습니다. 첫 판에서 구간 띠와 등급 경계와 함께 이력이 여기에 그려집니다.
Country values
- 타일
/api/v1/public/grix/risk-products/tiles/hlt/{z}/{x}/{y}.mvt- 관측 키
nis:IDX.HLT.security.health_security_risk:{ISO3}:{YEAR}:A
Series that read this index
Crosswalks and validity checks
Crosswalks map leaf indicators to source code lists; established indices are used for validity checks, never re-weighted as inputs.
| Code system | Leaf indicators mapped |
|---|---|
WHO_GHO | 22 |
WB_WDI | 18 |
SDG | 17 |
SPAR | 4 |
JEE | 4 |
FAO_FAOSTAT | 3 |
Platforms, standards and ways to take part
Field and service platforms of GCRI, GRF and GRA, the Nexus Risk Standards for this domain, learning, working groups and open calls. Every link is a live page.
인용과 재사용
See this index in every country profile
Each profile shows this index with its interval and class once released.
상태
Global Risks Index의 방법론, 구조, 정의는 검토와 의견 수렴을 위해 배포된 예비 작업 초안(2026)이며 이행용이 아닙니다. 관리되는 근거 마감에 따라 판이 공개되기 전까지는 어떠한 값도 표시되지 않으며, 공개 후 값에는 구간, 등급, 출처, 정정 경로가 함께 표시됩니다. 시뮬레이터는 귀하가 선택한 숫자에 공개된 방법을 적용할 뿐이며 NXS-GRX 값을 표시하지 않습니다.
NXS-GRX가 아닌 것
NXS-GRX는 연구 및 리스크 분석 정보입니다. 신용등급이나 ESG 등급이 아니며 등급 척도를 사용하지 않고, 금융상품의 벤치마크도, 공식 통계도, 긴급 경보나 공식 분류도, 자문도 아닙니다. 자연인 평가에 사용해서는 안 됩니다. 리스크 등급은 공개된 척도 위의 구간이며, 국가나 사람의 순위가 결코 아닙니다.
기관과 출처
The Nexus Consortium is stewarded by three independent not-for-profit institutions: The Global Centre for Risk and Innovation (GCRI), through GCRI US in Washington, DC and GCRI Canada in Ontario, with GCRI Canada as Lead Institution, Consortium Secretariat and lead contracting organisation; The Global Risks Forum (GRF); and The Global Risks Alliance (GRA). Technology, infrastructure and service providers work with the Consortium at arm’s length under written agreements, like every other external party in the public-private-planet model, and hold no role in its stewardship.
모든 값에는 출처 표시가 함께 제공되며, 각 출처는 고유한 라이선스를 유지합니다. 외부 명칭은 상호운용성을 위해서만 인용됩니다. Nexus가 작성한 텍스트는 공개 시 CC BY 4.0 적용을 예정합니다.
Avis en français
La méthodologie et les définitions du NXS-GRX sont un projet de travail préparatoire (2026). Le NXS-GRX est une information de recherche et d’analyse des risques : ni notation, ni indice de référence financier, ni statistique officielle, ni alerte, ni conseil. Les classes de risque sont des bandes sur une échelle publiée, non des classements.